MIT researchers are using living cells to target diseased brain areas and deliver tiny electronic devices that can modulate ...
The market is moderately consolidated, with AMSilk holding around 8.7% share in 2025, driven by its leadership in recombinant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback